RIPK1 Binds MCU to Mediate Induction of Mitochondrial Ca2+ Uptake and Promotes Colorectal Oncogenesis
Related Experiment Video
Updated: Feb 13, 2026

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
Published on: October 26, 2017
Fanxin Zeng1,2, Xiao Chen3, Weiyi Cui1,2
1Institute of Molecular Medicine, Peking University, Beijing, China.
Abstract:
The receptor-interacting protein kinase 1 (RIPK1) is an essential signaling molecule in pathways for cell survival, apoptosis, and necroptosis. We report here that RIPK1 is upregulated in human colorectal cancer and promotes cell proliferation when overexpressed in a colon cancer cell line. RIPK1 interacts with mitochondrial Ca2+ uniporter (MCU) to promote proliferation by increasing mitochondrial Ca2+ uptake and energy metabolism. The ubiquitination site of RIPK1 (RIPK1-K377) was critical for this interaction with MCU and function in promoting cell proliferation. These findings identify the RIPK1-MCU pathway as a promising target to treat colorectal cancer.Significance: RIPK1-mediated cell proliferation through MCU is a central mechanism underlying colorectal cancer progression and may prove to be an important therapeutic target for colorectal cancer treatment. Cancer Res; 78(11); 2876-85. ©2018 AACR.
Insights
Receptor-interacting protein kinase 1 (RIPK1) promotes colorectal cancer growth by enhancing mitochondrial calcium uptake. Targeting the RIPK1-MCU pathway offers a potential new treatment strategy for colorectal cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Receptor-interacting protein kinase 1 (RIPK1) is a key regulator of cell death and survival pathways.
- Dysregulation of RIPK1 signaling is implicated in various cancers.
Purpose of the Study:
- To investigate the role of RIPK1 in colorectal cancer progression.
- To identify molecular mechanisms by which RIPK1 influences cancer cell proliferation.
Main Methods:
- Analysis of RIPK1 expression in human colorectal cancer tissues.
- Overexpression of RIPK1 in a colon cancer cell line.
- Investigation of RIPK1 interaction with mitochondrial calcium uniporter (MCU).
- Assessment of RIPK1 ubiquitination site (K377) function.
Main Results:
- RIPK1 is upregulated in human colorectal cancer.
- Overexpressed RIPK1 enhances colon cancer cell proliferation.
- RIPK1 interacts with MCU, increasing mitochondrial calcium uptake and energy metabolism.
- RIPK1 ubiquitination at K377 is essential for its interaction with MCU and proliferative function.
Conclusions:
- The RIPK1-MCU pathway drives colorectal cancer cell proliferation.
- RIPK1-mediated mitochondrial calcium uptake is a critical mechanism in colorectal cancer.
- The RIPK1-MCU pathway represents a promising therapeutic target for colorectal cancer treatment.
More Related Videos
07:46Imaging Mitochondrial Ca2+ Uptake in Astrocytes and Neurons using Genetically Encoded Ca2+ Indicators GECIs
Published on: January 22, 2022
12:55Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Related Concept Videos
The Eukaryotic Promoter Region
Receptor-mediated Endocytosis
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes
Animal Mitochondrial Genetics
Export of Mitochondrial and Chloroplast Genes
The Equilibrium Binding Constant and Binding Strength